Gaois

Search direction

Search mode

Filter results

Collections

5 results in 3 documents

  1. #2463406

    Próifiolacsas éidéime tocsainí scamhóg le stéaróidigh ionanálaithe (sprae dáileoige, e.g. auxilosone).

    Prophylaxis of a toxic lung oedema with inhalative steroids (dosing spray, e.g. auxilosone).

    Commission Implementing Regulation (EU) 2022/964 of 10 June 2022 granting a Union authorisation for the biocidal product family ‘SOPUROXID’ (Text with EEA relevance)

  2. #2479778

    I gcás ionanálaithe: Deacrachtaí análaithe, casacht, éidéime scámhógach, masmas, urlacan.

    In case of inhalation: Breathing difficulties, cough, pulmonary oedema, nausea, vomiting.

    Commission Implementing Regulation (EU) 2022/1232 of 13 July 2022 granting a Union authorisation for the biocidal product family ‘INTEROX Biocidal Product Family 1’ (Text with EEA relevance)

  3. #294177

    (a) áirítear éifeachtaí greannaithe riospráide (a aithnítear le deirge logánaithe, éidéime, tochas agus/nó pian) a lagaíonn feidhm le siomptóim amhail casacht, pian, tachtadh agus deacrachtaí análaithe.

    (a) respiratory irritant effects (characterised by localised redness, oedema, pruritis and/or pain) that impair function with symptoms such as cough, pain, choking, and breathing difficulties are included.

    Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No 1907/2006

  4. #2463405

    D’fhéadfadh éidéime thocsaineach scamhóg tarlú má leantar leis an táirge a ionanálú in ainneoin éifeacht ghéar-ghreannaitheach (e.g. mura féidir láthair na contúirte a fhágáil).

    Formation of a toxic lung oedema is possible if product continues to be inhaled despite acute irritative effect (e.g. if it is not possible to leave the danger area).

    Commission Implementing Regulation (EU) 2022/964 of 10 June 2022 granting a Union authorisation for the biocidal product family ‘SOPUROXID’ (Text with EEA relevance)

  5. #293581

    Is é an mórchritéar a bhaineann le substaint a aicmiú mar ghreannaitheoir don chraiceann, mar a léirítear i mír 3.2.2.7.1, ná meánluach na scór d'éiritime/eschar nó d'éidéime arna ríomh in 2 ainmhí ar a laghad as 3 cinn de na hainmhithe a tástáladh.

    The major criterion for classification of a substance as irritant to skin, as shown in paragraph 3.2.2.7.1, is the mean value of the scores for either erythema/eschar or oedema calculated in at least 2 of 3 tested animals.

    Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No 1907/2006